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Summary
The adherence of Bordetella pertussis to human respiratory cilia is critical to the pathogenesis of
whooping cough but the significance of bacterial attachment to macrophages has not been
determined . Adherence to cilia and macrophages is mediated by two large, nonfimbrial bacterial
proteins, filamentous hemagglutinin (FHA), and pertussis toxin (PT) . PT andFHA both recognize
carbohydrates on cilia and macrophages; FHA also contains an Arg-Gly-Asp (RGD) sequence
which promotes bacterial association with the macrophage integrin complement receptor 3(CR3) .
We determined that virulent R pertussis enter and survive in mammalian macrophages in vitro
and that CR3 is important for this uptake process . We then determined the relative contribution
of CR3 versus carbohydrate-dependent interactions to in vivo pulmonary colonization using a
rabbit model. R pertussis colonized the lung as two approximately equal populations, one extracellular
population attached to ciliary and macrophage surface glycoconjugates and another population
within pulmonary macrophages. Loss of the CR3 interaction, either by mutation of FHA or
treatment with antibody to CR3, disrupted accumulation of viable intracellular bacteria but
did not prevent lung pathology . In contrast, elimination of carbohydrate-bound bacteria, either
by a competitive receptor analogue or an anti-receptor antibody, was sufficient to prevent pulmonary
edema . We propose that CR3-dependent localization ofR pertussis within macrophages promotes
persistence of bacteria in the lung without pulmonary injury. On the other hand, the presence
of extracellular bacteria adherent to cilia and macrophages in carbohydrate-dependent interactions
is associated with pulmonary pathology.
ordetelia pertussis is a Gram-negative coccobacillus that is
the causative agent ofwhooping cough. It has long been
recognized that R pertussis establishes pulmonary coloniza-
tion by adhering specifically to human ciliated epithelial cells,
and this interaction has been studied in detail in vitro (1) .
Recently, however, in vitro studies have shown that R per-
tussis also adheres specifically to human macrophages (2) and
can enter and survive within tissue culture cells (3-5) . The
purpose of this study was to determine the importance of
the interaction between R pertussis and macrophages during
pulmonary infection .
Bacterial adherence to cilia and macrophages is mediated
by two nonfimbrial bacterial proteins, filamentous hemag-
glutinin (FHA)t and pertussis toxin (PT) which are ex-
pressed only by virulent cells (1, 2) . These proteins are func-
tional either when bound to the bacterial surface or when
secreted into the surrounding medium during growth and
serve as bifunctional ligands bridging the bacterial surface
and glycoconjugates on eukaryotic cell membranes (1, 6) . Both
'Abbreviations used in this paper. FHA, filamentous hemagglutinin ; PT,
pertussis toxin; RGD, Arg-Gly-Asp sequence .
adhesins are unusually large molecules with multiple binding
affinities, features reminiscent of eukaryotic extracellular matrix
proteins . IT is a 105-kD hexameric protein composed offive
different subunits with binding affinities for several carbohy-
drates (6-9) . Subunits 2 and 3 bear eukaryotic-like carbohy-
drate recognition domains (9) . FHA is a 220-kD protein that
binds galactose-containing glycoconjugates on both cilia and
macrophages (2, 6) . In addition to a carbohydrate recogni-
tion domain, an Arg-GlyAsp (RGD) triplet at position 1097-9
ofFHA (10) promotes adherence ofR pertussis to the macro-
phage integrin CR3 (CD11b/CD18) (2) . It is known that
particles phagocytosed via CR3 do not engender an oxida-
tive burst (11), suggesting this route of entry might promote
survival ofR pertussis within the macrophage resulting in
a sequestered reservoir of bacteria within the large airways.
In this study we determined that CR3 contributes to the
localization ofR pertussis within the alveolar macrophage in
vivo and that intracellular bacteria constitute as much as half
of the total viable number ofbacteria in the rabbit lung early
in the course of colonization . However, intracellular bacteria
do not appear to contribute to pulmonary pathology . In con-
trast, R pertussis bound to the surfaces of cilia and macro-
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pulmonary pathology .
Materials and Methods
Bacterial Strains.
￿
The strains used are derivatives of the viru-
lent, phase I B. penussis strain 536 (2, 10, 12) . BP-TOX6 contains
a deletion of the 3 .4-kb BstEll fragment encompassing thePT op-
eron . BP101 contains an inframe 2.4-kb deletion withinfhaB which
eliminates carbohydrate and integrin recognition . BP1098 carries
a site-directed mutation within fhaB resulting in substitution of
Ala for Gly at position 1098 of the RGD site. BP101-TOX6 and
BP1098-TOX6 are derivatives into which theTOX6 mutation was
introduced . Strains were grown for 3 d at 37°C on Border Gengou
agar supplemented with 15% sheep blood .
Colonization Assays.
￿
New Zealand White rabbits (2 kg; Hare
Marland, Nutley, NJ) were anesthetized with ketamine and xyla-
zine, the trachea was cannulated (19 G 7/8 butterfly infusion set ;
Abbott Laboratories, North Chicago, IL) through a tracheostomy,
and lOs bacteria (in 0.2 ml saline) were introduced intratracheally
as described in a model of pulmonary colonization (13, 14) . To in-
terrupt carbohydrate or CR3-dependent events, some animals were
treated intratracheally with one of the following within 10 min
ofthe bacterial challenge : lactose or sialic acid (0.1M); mAbs recog-
nizing CR3 (mAb IB4, 0.5 mg/kg ; courtesy of Merck Sharpe &
Dohme, Inc ., Rahway, NJ, [reference 15]), or the blood group de-
terminants Lewis a (mAb 23.24) or A (mAb 69.4) (0.2 mg/kg;
courtesy of Ciba-Geigy, Basel, Switzerland, [reference 6]) . 24 h
after the bacterial challenge, the lungs were harvested, weighed,
homogenized, and titered for bacterial CFUs . Pulmonary edema
was measured by comparing lung wet weight to that ofuninfected
lungs (normal = 4.7 t 0.4 g) . To ascertain ifbacteria were within
macrophages, excised tracheas were lavaged (10, 11) to harvest intra-
airway macrophages, and lavage fluids were centrifuged, washed
and placed on two slides. One slide was fixed in buffered formalin
(16) and stained with anti-Bordetella fluorescent antibody (1:40,
Bacto-FA Bordetella pertussis; Difco Laboratories, Inc ., Detroit, MI)
to visualize extracellular bacteria . The duplicate slide was fixed in
methanol (16) and stained with the same fluorescent antibody to
visualize both intra- and extracellular bacteria. The difference in
the number ofbacteria visualized by the two preparations was taken
as a measure of the number ofintracellular bacteria . Values are ex-
pressed as the mean t SD of the number of bacteria associated
with 25 cells. Statistical significance was determined by student's
t test .
In Vitro Adherence Assays.
￿
Quantitation of viable intracellular
bacteria was performed using pulmonary alveolar macrophages from
healthy rabbits or human peripheral blood monocytes at day 4-6
in tissue culture (2) . Bacteria and eukaryotic cells were incubated
in medium RPMI (Sigma Chemical Co., St . Louis, MO) at a rela-
tive density of 100:1 for30 min on a tumbler at 37°C. Suspensions
were centrifuged to sediment the cells and the supernatant fluid
containing the majority of nonadherent, extracellular bacteria was
discarded . The cells were then incubated at 37°C in R.PMI sup-
plemented with gentamicin (50 ug/ml) to kill extracellular bac-
teria . To determine the number of viable intracellular bacteria,
samples were taken at 30 min intervals over 6 h and the gentamicin
was removed by centrifugation of the cells at 10,000g . Cells were
resuspended in 0.1% Triton X-100 and viable bacteria released from
the cells were titered byCFUs . In parallel, samples were also taken
at hourly intervals, fixed with formalin or methanol, and stained
as described above to visually confirm the number ofintra- versus
extra-cellular bacteria .
1144 Integrin-mediated Localization of Bordetella pertussis
as described above to visually confirm the number of intra- versus
extra-cellular bacteria .
Results
CR3 Promotes Accumulation of Viable R pertussis Within
Macrophages In Vitra R pertussis were incubated in vitro
with macrophages cultured fromhuman peripheral blood or
harvested from rabbit lungs. The presence of intracellular bac-
teria after a 30-min coincubation was determined by quanti-
tation ofbacteria surviving incubation ofthe bacteria-macro-
phage mixtures with gentamicin . 1, 2, and 4 h after addition
ofgentamicin, the number ofviable wild typeBP536 recov-
ered per 10 human macrophages was 3.1 t 0.1, 3.6 ± 0.4,
and 5.6 ± 0.7, respectively . No avirulent BP537 were recov-
ered under the same conditions . Thus, R pertussis appeared
to enter, survive, and slowly multiply within macrophages.
The determinants of intracellular localization were exam-
ined by comparing the relative abilities of mutant strains to
enter the macrophages . Recovery ofviable bacteria from mac-
rophage lysates differed greatly between strains. All strains
carrying the FHA RGD region were recovered from within
macrophages ofboth species while those lacking this region
were not, even if carbohydrate-dependent adherence ofbac-
teria to the macrophages was intact (Table 1) . This was even
more apparent when values were normalized for the ability
of each strain to adhere to the macrophage surface. For in-
stance, galactose inhibits adherence of BP536 by half but
recovery from within cells remained high (Table 1) and intra-
cellular bacteXia were seen by direct visualization (Fig. 1, row
B, number of bacteria inM> F) . In contrast, BP1098/TOX6,
which also adheres half as well as the wild type, showed very
low recovery from within cells (Table 1) and few visually dis-
cernable intracellular bacteria (Fig. 1, row A, number of bac-
teria inM = F) . These results indicated that bacterial uptake
and survival were promoted through the interaction of the
RGD region, as opposed to the carbohydrate recognition do-
main, of FHA with macrophages.
CR3 Promotes Accumulation ofViableR pertussis Within Mac-
rophages In Viva To determine if virulent R pertussis local-
ized within intra-airway macrophages early in the course of
colonization of the rabbit lung, intracellular versus extracel-
lular bacteria were distinguished by differential fixation of
cells from bronchoalveolar lavage fluids. In samples fixed with
formalin (Fig. 2, column F), numerous virulent bacteria were
seen adherent to the surface ofthe macrophages (12 ± 3 bac-
teria/cell) . However, stained bacteria were clearly more abun-
dant (>25 bacteria/cell) and could be seen clustered within
macrophages upon fixation of duplicate specimens with meth-
anol (Fig. 2, columnM) . Thus, virulentB. pertussis appeared
to be present inside alveolar macrophages within the first 24 h
of infection of the rabbit tracheobronchial tree . Inhibition
experiments were then performed to assess the relative con-
tribution of CR3-dependent and carbohydrate-dependent ad-
herences ofR pertussis to uptake into macrophages in vivo.
The CR3-dependent interaction was eliminated by aerosol
treatment with antibody to CR3, leaving the carbohydrate-
dependent binding interactions intact . Although extracellularbacteria were somewhat reduced in number (4.3 ± 3 bac-
teria/cell ; Fig . 2, panels B and F) as compared to the wild
type, no additional intracellular bacteria were visualized upon
fixation with methanol (4.7 ± 2 bacteria/cell) (Fig. 2, panels
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' Tox = pertussis toxin; RGD - Arg-Gly-Asp sequence of FHA; CRD = carbohydrate recognition domain of FHA.
t Adherence index expressed as percent of wild type adherence to human macrophages as published in reference 2 .
S 100% - 3.6 ± 0.4 bacteria/10 macrophages . Values are means t SD from three experiments .
B andM), indicating reduced bacterial accumulation within
the airway macrophage. In contrast, inhibition ofcarbohydrate-
dependentbindingby treatmentwith thecompetitive receptor
analog lactose or the anti-receptor antibodymAb 23.24, re-
Figure 1.
￿
Effect of interruption ofRGD versus carbohydrate-dependent attachment on uptake of bacteria into macrophages . The RAD-containing
strain BP1098TOX6 (row A) or wild-type BP536 plus galactose (50 mM) (row B) were incubated with human macrophages. Extracellular attached
bacteria (visualized by fixation ofcells with formalin [Fl) and total intracellular and extracellular bacteria (visualized by fixation ofcells with methanol
[Ml) were stained with fluorescent anti-Bordetella antibody. Uptake into the macrophage (no . of bacteria in M-F) was blocked by the RAD mutation
but not the carbohydrate competitive inhibitor.
Table 1 . Determinants of Intracellular Localization and Survival ofBordetella pertussis within Mammalian
Viable
(percent
Macrophages
intracellular bacteria
of wild type at 2 h)
Rabbit alveolar Human blood
Strain Active adhesin" Alt macrophage macrophage
BP536 FHA+Tox 100 1005 100
BPTOX6 FHA RGD+CRD 100 52 t 7 43 t 6
BP536+galactose FHA RGD 54 72 t 12 64 ± 16
BP1098/TOX6 FHA CRD 58 3t8 7t9
BP101/TOX6 None 4t8 6t6Figure 2 .
￿
Fluorescence micrographs of alveolar macrophages obtained by lung lavage 24 h after infection. left and right hand panels in each row
are duplicate samples fixed with either formalin (F) allowing staining of only extracellular R penussis, or methanol (M) allowing staining of intra-
and extracellular bacteria. Animals were challenged with the parental strain BP536 (row A), BP536 plus anti-CR3 antibody (row B), or BP536 plus
either lactose or anti-receptor antibody anti-Lewis a (row C) .Figure 3 .
￿
Effect ofmutation ofFHA on the numberofbacteria in lungs
at 24 h. Rabbits (at least four per group) were challenged with the desig-
nated strain and the total viable bacterial number was determined from
lung homogenates and expressed as a per cent of the wild type (WT)
strain 536 .
duced the number of extracellular bacteria (3.6 ± 3 bac-
teria/cell) but uptake persisted (15 ± 5 bacteria/cell) (Fig.
2, row C) . The specificity of these treatments was indicated
by the lack of effect on number or distribution of adherent
wild type bacteria in animals receiving the noncompetitive
carbohydrate sialic acid or antibody 69.4 which does not recog-
nize the R pertussis receptor (data not shown) . Thus, CR3
appeared to be ofgreater importance to directing the adherent
bacteria into the macrophages than the carbohydrate-dependent
interaction .
Pathophysiologic Significance ofIntracellularR pertussis .
￿
To
determine the viability ofbacteria residing within macrophages
during natural infection and the contribution of this popula-
tion to pulmonary pathology, R pertussis deficient in intra-
cellular localization were compared to wild-type strains for
the ability to colonize the pulmonary tract of the rabbit and
cause pulmonary edema (Fig . 3) . Virulent BP536 colonized
the lung in high titer (3.2 ± 0.4 x 106 cfu/ml lung ho-
mogenate) and produced pulmonary edema, while theFHA-
PT-double mutant (BP101TOX6) did not (< 103 cfu-ml
lung homogenate) . Elimination of all FHA-mediated adher-
ence (BP101), decreased colonization to 18 ± 12% of pa-
rental values, reflecting the dominance of this adhesin in vivo.
To determine the location of bacteria adherent by FHA,
animals were challenged with BPTOX6, a mutant deficient
in adherence to cilia but not macrophages (1, 2) . FHA
dependent adherence to macrophages (by RGD and car-
bohydrate-dependent mechanisms) contributed significantly
to the total lung bacterial load as evidenced by persistent lung
colonization (46 ± 7%) . This half of the lung population
was predominantly involved in RGD- rather than carbohy-
drate-dependent interactions as indicated by the loss ofcoloni-
zation upon loss of the RGD site in mutant BP1098TOX6
(adheres only in a carbohydrate-dependent fashion to macro-
phages ; Fig. 3) .
We interpret these studies with the mutant strains to sug-
gest that the association viaFHA ofB . pertussis with alveolar
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Figure 4 .
￿
Effect ofreceptor blockade on pulmonary colonization. Rabbits
(at least four per group) were challenged with BP536 plus the designated
anti-adherence modalities . Lactose and anti-Le a antibody are known to
block carbohydrate dependent adherence while sialic acid or anti-A anti-
body are ineffective. Anti-CR3 is known to block the CR3 interaction.
macrophages contributes substantially to the total bacterial
load in the lung, with macrophage- and cilia-associated popu-
lations reaching approximately equal numbers early in the
course of colonization of the lung . This is consistent with
the similar and substantial decreases in total lung colony counts
in rabbits receiving anti-carbohydrate (lactose or anti-Lewis
a antibody) or anti-CR3 (mAb IB4) directed treatments (Fig.
4) . Although numerically similar, the cilia- versus macrophage-
associated populations ofR penussis did not contribute equally
to pulmonary disease . When pulmonary edema was assessed
in animals challenged with the various mutants (Fig. 5), in-
terruption of the RGD interaction by the RAD mutation
or antibody to CR3 did not decrease the generation of pul-
monary edema. Only treatment of animals with lactose or
anti-Lewis a antibody blocked pulmonary edema .
Figure 5 .
￿
Effect ofanti-adherence modalities on pulmonary edema and
location of bacterial colonization . Rabbits were challenged as in Figs. 3
and 4 andlung weight was determined at 24 h as a measure ofpulmonary
edema. Control lung weight was 4.7 ± 0 .4 g while the parental strain
(VIR+, BP536) induced pulmonary edema with a lung weight of 6 .1 t
0 .5 g (' = p< 0.01). The location and relative density of bacteria (0
none, + - few, + + + + = many) were determined by differential
staining of lavage fluids or sections of trachea or distal lung as in Figs .
1 and 2 .Discussion
R pertussis has been shown to invade and survive within
tissue culture cells (3, 4), and preliminary evidence suggested
these bacteria could multiply in leukocytes in vitro (5) and
could be found within the alveolar macrophages ofsome pa-
tients withHIV disease subjected to bronchoalveolar lavage
for diagnosis ofpulmonary infection (K . Bromberg, Down-
state Medical Center, Brooklyn, NY, personal communica-
tion) . Our results demonstrate that these findings are rele-
vant to the pulmonary tract where R pertussis resides
throughout the natural course ofwhooping cough . In vitro,
R pertussis was shown to enter cultured human macrophages
and freshly harvested rabbit alveolar macrophages by subverting
a natural leukocyte-specific phagocytic apparatus involving
the integrin CR3 . Uptake was followed by bacterial survival
and slow multiplication over 4 h . In a rabbit model ofinfec-
tion, differential staining oflavage fluids indicated thatR per-
tussis established an intracellular state within alveolar macro-
phages early in the course of pulmonary colonization . CR3
appeared to promote uptake ofbacteria into macrophages in
vivo as evidenced by the lack of intracellular bacteria in la-
vage specimens from animals challenged with theRAD mu-
tant or from animals challenged with the wild-type strain
in conjunction with anti-CR3 antibody . Since CR3 is a
leukocyte-specific integrin, such intracellular localization is
not likely to extend to other cells ofthe respiratory epithelium .
Approximately halfofthe totalbacterial population recover-
able from the lung appeared to reside within macrophages .
However, pulmonary pathology could not be attributed to
this population since even a 90% decrease in total lung bac-
terial number achievable by treatment with anti-CR3 antibody
for 24 h did not diminish pulmonary edema . Reduction of
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